SOUTH AFRICAN ONCOLOGY CONSORTIUM
It is all about Quality Cancer Care

Bulletin Board 


Updated News

04/12/2017

PROVIDING QUALITY ONCOLOGY CARE

The South African Oncology Consortium is proud to introduce SAOC’s new acting CEO, Dr Silvia Cornejo-Vega, who shares SAOC’s passion for the delivery of appropriate quality care and sustainability in oncology...   More


04/12/2017

SAOC Matters

SAOC, whilst remaining committed to its core business as a managed care company, is in an exciting process of renewal, exploring new opportunities in the health sector.   More


03/01/2017

Agility Health - Spectramed's New Oncology Managed Care Provider

In line with Spectramed Medical Scheme’s unwavering commitment to streamlining its processes for enhanced service delivery, the Scheme is pleased to announce that it has appointed Agility Health as its...   More


02/08/2017

SAOC Tiered Oncology Guideline Review 2017

This year the SAOC will commence with the review of the chemotherapy guidelines mid 2017. We urge you to submit all submissions for inclusion into the guidelines by 31 May 2017. We will not consider any late...   More


24/10/2016

RETIREMENT: DR M A Coccia-Portugal

The time has come for Dr MA Coccia-Portugal, practitioner in Medical Oncology, to “slow-down”. After more than 40 years of dedication to the care of cancer patients in our country she has decided to pass on...   More


19/10/2016

Oncologist Required

A client of PSM Personnel CC, based in Krugersdorp, requires an oncologist for their growing practice. Candidates need to be registered with HPCSA as an oncologist and there is a possibility of going into...   More


10/06/2016

SAOC Company Matters

The South African Oncology Consortium held its Meeting of the Board of Directors on Thursday, 19 May 2016. It gives us great pleasure to announce that the Board has elected Dr Adam Nosworthy as the new...   More


22/04/2016

Treatment Authorisation and URC Peer Review Turnover Time

The SAOC URC Peer Review Turnover Time for cases reviewed is at the most 72 hours, this being said it is subject to comprehensive clinical information submitted with the first request as well as the response...   More


29/01/2016

Policy Statement Approval and Administration of Ipilimumab (Yervoy®)

The SAOC is notably concerned by submissions from treating physicians for approval of Ipilimumab in metastatic melanoma and subsequent requests from medical schemes regarding approval of Ipilimumab. Please...   More


27/01/2016

SAOC Tiered Oncology Guideline Review 2016

This year the SAOC will commence with the review of the chemotherapy guidelines mid 2016. We urge you to submit all submissions for inclusion into the guidelines by 31 May 2016. We will not consider any late...   More